January 12, 2015
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced the GenetiSure Pre-Screen Kit, a high-throughput oligonucleotide microarray for screening aneuploidy and other genomic aberrations in the 5- to 10-Mb range from single cells in three- and five-day embryos. Agilent's kit allows for a turnaround time of less than eight hours from DNA extraction [...]
BioLife Solutions Reports Preliminary Revenue for 2014
January 12, 2015
BOTHELL, WA —- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues (“BioLife” or the “Company”), today announced preliminary revenue for the fourth quarter and full year 2014 and a recap of operational accomplishments. [...]
January 12, 2015
Hilden, Germany -– QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) announced today the CE-IVD marking of its novel liquid biopsy-based companion diagnostic that analyzes circulating nucleic acids obtained from blood samples to assess an important genomic mutation in patients with non-small cell lung cancer (NSCLC), the most common form of this cancer. The registration, which [...]
Illumina Expands World’s Most Comprehensive Next-Generation Sequencing Portfolio
January 12, 2015
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the world's most comprehensive next-generation sequencing (NGS) portfolio with the launch of the HiSeq X Five System and HiSeq 3000/4000 Systems. Over the last five years, the HiSeq Sequencing System family has been established as the platform of choice for high-throughput, production-scale sequencing laboratories. [...]
Illumina, Inc. has added a news release to its Investor Relations website.
January 11, 2015
EDINBURGH, Scotland & GLASGOW, Scotland -- A major investment in gene sequencing technology will secure Scotland's place as a world leader in a genomics revolution that is set to transform healthcare. The initiative will enable scientists and clinicians to access equipment that can decode the entire genetic make-up of a person for less than £750. [...]
QIAGEN acquires Enzymatics enzyme solutions unit, a leading enabler of NGS applications
January 11, 2015
HILDEN, Germany and BEVERLY, Massachusetts -– QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Prime Standard QIA) today announced the acquisition of the Enzyme Solutions Unit of Enzymatics, a world leader in the development, manufacturing, and OEM supply of enzymes essential to driving the adoption of Next-Generation Sequencing (NGS) and other genetic analysis technologies in life sciences research [...]
January 11, 2015
SANTA CLARA, Calif. -– Affymetrix, Inc. (NASDAQ: AFFX) will be highlighting several new genotyping arrays at the 2015 Plant and Animal Genome Conference (PAGXXIII) for applications in breeding and routine analysis. Affymetrix now offers the largest catalog of arrays for research and applied agriculture markets. The newest arrays, Axiom® Porcine Genotyping Array and Axiom Equine [...]
ArcherDX Launches from QIAGEN Acquisition of Enzymatics
January 11, 2015
Boulder, Colo. and Beverly, Mass. -— ArcherDX, Inc., the NGS applications company, today announced the formation of a new, independent company, which is focused on the development of the Archer™ line of next-generation sequencing (NGS) products. ArcherDX is the result of a business unit reorganization, also announced today, in which QIAGEN N.V. (NASDAQ: QGEN, Frankfurt [...]
Bioo Scientific Releases 18S ITS rRNA Library Prep Kit to Simplify Eukaryotic Metagenomic Studies
January 10, 2015
Austin, TX -- The NEXTflex™ 18S ITS Amplicon-Seq Kit simplifies the preparation of multiplexed amplicon libraries spanning the ITS1 and ITS2 hypervariable regions of eukaryotic 18S ribosomal RNA (rRNA) genes to permit the fast and cost-effective characterization of uncultured fungal and micro-eukaryotic organisms. Up to 384 multiplexing barcodes are available with this kit, to greatly [...]
WuXi PharmaTech Acquires NextCODE Health to Create Global Leader in Genomic Medicine
January 9, 2015
SHANGHAI -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, announces that it has acquired NextCODE Health, a leading genomic analysis and bioinformatics company with operations in the United States and Iceland, [...]

